Interestingly, Di Benedetto and her group reported Api5 inhibition to reduce angiogenesis and increase in apoptosis in xenograft models, thereby highlighting the potential use of Api5 as a therapeutic target in metastatic breast cancers that are resistant to chemotherapy [13]. The gene discussed is API5; the disease is breast carcinoma.